Zingiber officinale Roscoe, Ginger, has been used in folk medicine as a medicinal plant, as well as a spice and food in many countries. This research was carried out to evaluate the antiparasitic effect of ginger root extract (GE) and GE/F1 (fraction 1 obtained from GE) against Toxoplasma gondii (T. gondii) in vitro and in vivo. The effect of GE and GE/F1 against the proliferation of T. gondii-infected C6 cells and T. gondii were evaluated by several indicators such as MTT assay, nuclear staining, immunofluorescence staining, apoptotic proteins and animal testing. GE/F1 strongly inhibited the proliferation of T. gondii-infected C6 cells and T. gondii in a dose-dependent manner compared with sulfadiazine. After T. gondii invasion, C6 cells induced the activation of caspase-3, bax, p53 and p21 related to apoptosis, and GE/F1 effectively suppressed the expression of caspase-3, bax, p53 and p21 causing cell death of the infected host cells. In addition, INF-γ, and IL-8 levels, and the viability of T. gondii-infected mice treated with GE/F1 (500 μg/ml) were not changed or increased during the period of the experiment. These results demonstrate that GE/F1 not only induces anti-T. gondii effects causing the inactivation of apoptotic proteins in infected host cells through the direct inhibition of T. gondii but also has antiparasitic properties which inhibit inflammatory cytokine secretion in vivo.
INTRODUCTION
Toxoplasma gondii (T. gondii) is a protozoan parasite which causes infection of the central nervous system in HIV/AIDS patients and chronic toxoplasmosis in young children or adults with the impaired immune system (Luft and Remington 1992) . T. gondii is a typical infectious organism that contains micro-organelles such as mitochondria, Golgi, micropore, rhoptries, dense granules, and micronemes (Joiner and Roos 2002) . T. gondii causes infection stages such as the tachyzoites, bradyzoites and sporozoites in humans and animals, which also induces the progressive proliferation pathway of two stages (the cyst stage and the oocyst stage) when it proliferates in host cells. T. gondii forms parasitophorous vacuole membrane (PVM) after invasion of host cells. PVM not only provides T. gondii with the nourishment but also protects T. gondii from acidification (Dubey et al. 1998) . People are infected through the placental infection which is transmitted to the fetus from a mother, who may become infected by eating raw or undercooked meat and contagion by sporulated oocysts in soil or cat feces.
Typically, sulfadiazine, pyrimethamine, and atovaquone have been used in the clinic to treat T. gondii. However, their side effects are often seen in patients. Until recently, studies of medicinal plants for the treatment of toxoplasmosis have been rarely reported. In this aspect, researches on effective and new substance of relatively low toxicity are urgently needed. Zingiber officinale Roscoe, commonly known as ginger, has been widely used as an herbal medicine and in folk medicine, as well as a spice and food in many countries around the world. Furthermore, it has been used for the treatment of human diseases such as common cold, cough, dyspepsia, diarrhea, and headache in Asia. Ginger has been reported to have the gastroprotective effects (Yamahara et al. 1988) , and inhibitory effects against nausea and vomiting (Ernst and Pittler 2000) , which is also known to have strong anxiolytic and anti-emetic activities (Vishwakarma et al. 2002) . Ginger induces extensive bioactivities including anti-inflammatory (Grzanna et al. 2005) , anticancer (Shukla and Singh 2007) , antioxidant (Jaqetia et al. 2003) , antimicrobial effects (Ficker et al. 2003) .
Its main chemical components are natural compounds that cause physiological activities such as gingerenones A, B, C (Endo et al. 1990 ), gingerdiol (Kikuzaki et al. 1992) , 6-, 8-, 10-Gingerol (Hiserodt et al. 1998) , paradol, shogaol (Ma et al. 2004) , and essential oil (Singh et al. 2008) .
Recently, the 10-shogaol and 1-dehydro-6-gingerdione isolated from ginger partially activate the serotonin 5-HT 1A receptor which is widely expressed in central nervous system (CNS) (Nievergelt et al. 2010) . Ginkgo biloba L. and Glycyrrhiza glabra L. are known as G. biloba, and G. glabra respectively. The extract of G. biloba causes anti-inflammatory (Kotakadi et al. 2008) , molluscicidal (Yang et al. 2008) , antimicrobial (Mazzanti et al. 2000) , and anticancer activities (DeFeudis et al. 2003) . The combination treatment of ginger and G. biloba was reported to cause neuroprotective effects (anti-anxiety effects and effects on brain's learning and memory) in various behavioral tasks (Hasenöhrl et al. 1998 ). In addition, this combination preparation also shows the memory-enhancing effects in aged animals (Topic et al. 2002) . G. glabra has a variety of biological effects such as anticancer (Kanazawa et al. 2003) , antimicrobial (Gupta et al. 2008) , and antiviral activities (Fiore et al. 2008) , and its extract has been utilized as a food additive in food industry recently. These researches not only indicate the various biological activities of medicinal plants but also demonstrate their physiological effects in vitro and in vivo.
Until recently, the effective herbal medicine for the treatment of toxoplasmosis hasn't been developed yet, even though drugs such as sulfadiazine and pyrimethamine have been used as anti-T.
gondii drugs in hospital. For these reasons, we investigated the anti-T. gondii effects of ginger, G. glabra, and G. biloba that have been used as medicinal plants and as food in many countries.
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MATERIALS AND METHODS
Materials
Fetal bovine serum (FBS), antibiotics and trypsin-EDTA were purchased from Invitrogen 
Preparation of extracts and fractions
The dried ginger, G. glabra, and G. biloba were provided from the Oriental Medical Center, Kyung Hee University (Seoul, Republic of Korea). The powdered roots of ginger (2 kg) and G. glabra (2 kg), and the powdered leaves of G. biloba (2 kg) were extracted using 4 L of methanol at room temperature for 24 h, respectively. After extraction, these extracts were filtered by filter paper and vacuum pump, and then they were evaporated under reduced pressure using a concentrator in a vacuum at 35 °C. Among these extracts, ginger extract (GE) strongly inhibited the proliferation of C6 cells infected with T. gondii (T. gondii-infected C6 cells) and T. gondii compared with other extracts. GE was melted with methanol, and it was coated with silica gel. The coated GE was loaded onto a cotton wool pad at the top of the silica gel column and divided with various partitions 6 by silica gel column chromatography method using CHCl 3 -MeOH eluate. All fractions were analyzed by the thin layer chromatography (TLC), and then we obtained nine fractions (column fractions obtained from GE) including GE/F1 (fraction 1 obtained from GE). Among these fractions, GE/F1 strongly inhibited the proliferation and viability of T. gondii-infected C6 cells and T. gondii. Sulfadiazine (SF) was used as a treatment-positive group to evaluate whether or not GE/F1 causes anti-proliferative effect against T. gondii.
Animals
BALB-c/mice (4 weeks, n=150) were purchased from DaeHan Bio-Link Co., Ltd. Korea, and all animal were kept at 22 ± 0.5 °C and 12 h-light/dark cycle in a controlled environment of a central animal care facility of the Kyung Hee University School of Medicine. Food and water were provided ad libitum. The facility was strictly maintained in accordance with National guidelines of the National Institutes of Health Guide for the Care and Use of Laboratory Animals.
Cell lines and culture conditions of T. gondii
Rat C6 glioma cells (C6 cells) were purchased from Korean Cell Line Bank at Seoul National University, and Rat DI TNC1 normal brain cells (DI TNC1 cells) were purchased from American Type Culture Collection (U.S.A). Cells were cultured in RPMI medium 1640 containing 2 mM L-glutamine, supplemented with 10% fetal bovine serum (FBS), 100 units/ml penicillin and 100 μg /mL streptomycin (Biofluids, Rockville, MD, U.S.A) in a humidified atmosphere containing 5% CO 2 in air at 37 °C. The RH strain of Toxoplasma gondii (T. gondii) was suspended with 1X PBS, which was injected in the abdominal cavity of each BALB-c/mouse. After 3 days of the injection, T. gondii was collected from peritoneal fluids of each mouse, which was maintained in the abdominal 7 cavity of mice before the use of in vitro and in vivo respectively. In vitro study, C6 cells were infected with T. gondii (C6 cells: T. gondii=1: 10).
MTT assay on the proliferation and cell viability
To evaluate the effects of ginger, G. glabra, and G. biloba extracts on the proliferation and viability of T. gondii-infected C6 cells, we investigated the viability of T. gondii-infected C6 cells exposed to these extracts. C6 cells were seeded in a 24 well plate (1 × 10 5 cells/well), which were infected with T. gondii (1 × 10 6 tachyzoites/well) after 24 h. T. gondii-infected C6 cells were incubated with different concentrations (30-240 μg/ml) of ginger, G. glabra, and G. biloba extracts respectively, and their viability was determined by MTT assay. T. gondii was seeded in a 24 well plate (5 × 10 6 /well), which was incubated with different concentration (30-240 μg/ml) of GE, GE/F1, and SF for 24 h respectively. The PR (the proliferation rate) of T. gondii-infected C6 cells and T. gondii was calculated as follows: OD control -OD test sample /OD control × 100 %. Optical absorbance was measured at a wavelength of 570 nm using an ELISA leader.
Microscopic observation of T. gondii in C6 cells
C6 cells were seeded in a 24 well plate (5 × 10 4 /well), which were incubated at 37 °C for 24 h. C6 cells were infected with T. gondii (5 × 10 5 tachyzoites/well), and then T. gondii-infected C6 cells were treated with 240 μg/ml of GE/F1 for 24 h. The morphological changes of C6 cells and T.
gondii-infected C6 cells were observed under a light microscope (Nikon Eclipse TE 2000-U, Japan). 8 This assay was performed as the method of Latt and Stetten. Hoechst 33342 is a cell-permeable nuclear staining reagent which emits blue fluorescence when it combines to dsDNA. C6 cells were seeded in a 24 well plate (5 × 10 4 cells/well), which were infected with T. gondii (5 × 10 5 tachyzoites/well). T. gondii-infected C6 cells were incubated with 120 μg/ml of GE/F1, and SF for 24h respectively. After washing with 1X PBS, T. gondii-infected C6 cells were fixed in 1X PBS containing 5% formaldehyde for 30 min, which were washed with 1X PBS and stained with a final concentration of 20 µM (Hoechst 33342) for 30 min in the dark. After staining, cells were washed with 1X PBS three times, and their nuclei were observed under a UV fluorescent microscope (Nikon Eclipse TE 2000-U, Japan).
Nuclear staining of T. gondii-infected C6 cells
Immunofluorescence of PVM in T. gondii-infected C6 cells
C6 cells were seeded onto cover slips in a 24well plate (5 × 10 4 /well), which were infected with T. gondii (5 × 10 5 tachyzoites/well). T. gondii-infected C6 cells were incubated with 120 μg/ml of GE/F1 and SF for 24 h respectively. After washing with 1X PBS, they were fixed with 3% formaldehyde for 10 min and 0.05% (v/v) Triton X-100 for 5 min. The cells were blocked with 1X PBS solution containing 1% BSA for 1 h at room temperature after washing. Mouse monoclonal anti-PVM antibody was diluted with 1:100 (v/v) using 1% BSA/PBS, and then the cells were incubated with anti-PVM antibody solution at room temperature for 1 h. After washing, goat anti-mouse IgG-FITC-conjugated secondary antibody was diluted with 1:100 (v/v) using 1X PBS, which was added to each well. The cells were incubated at room temperature for 1 h, which were washed with 1X PBS three times. Their fluorescence was observed under a UV fluorescent microscope (Nikon Eclipse TE 2000-U, Japan). 9 Western blot analysis C6 cells were incubated in a 6well plate (1 × 10 5 /well) for 24 h, which were infected with T. gondii
(1 × 10 6 tachyzoites/well). T. gondii-infected C6 cells were treated with different concentrations (60-120 μg/ml) of GE/F1 and SF for 24 h respectively, which were harvested to analyze western blotting. The pellets were lysed using RIPA lysis buffer (Elpis Biotech). The protein concentrations were measured at 595 nm using the Bio-Rad protein assay kit and 1% BSA as standard. Equal amounts of protein were loaded onto 12% SDS-PAGE and transferred to a nitrocellulose membrane.
Membranes were blocked with 1X PBS (5% skim-milk) containing 0.05% Tween-20 at room temperature for 1 h, and they were also washed with 1X PBS containing 0.05% Tween-20 five times. The membranes were incubated with the corresponding primary antibodies to p53 (1: 500), p21 (1: 500), caspase-3 (1:500), bax (1: 500) and β-actin (1: 2,000) respectively, overnight at 4 °C.
After membranes were washed with 1X PBS containing 0.05% Tween-20, they were incubated with goat anti-mouse, goat anti-rabbit or rabbit anti-goat IgG HRP conjugated secondary antibody at room temperature for 2 h. After repeating the washing step, protein bands were visualized using the ECL western blotting analysis kit (Millipore Corporation, Billerica, MA 01821 U.S.A). All antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA), Cell Signaling (Cell Signaling Technology, Inc., Danvers, MA), and R&D System (Minneapolis, MN, U.S.A).
The viability of T. gondii-infected mice
Sixty animals were divided into normal (n=15) and experimental groups (3 groups, n=45). T. gondii was seeded in a 12 well plate (1 × 10 7 /well), which was incubated with 250, and 500 μg/ml of GE/F1 for 24 h. T. gondii treated with 250 and 500 μg/ml of GE/F1 was harvested before the injection in the abdominal cavity of each mouse in experiment group, which was washed with 1X 10 PBS three times. The pellets were also suspended with 1X PBS, which was injected in the abdominal cavity of each BALB-c/mouse in experimental groups. Mice infected with T. gondii (T.
gondii-infected mice) were used as infection positive group, and all animals were kept in a central animal care facility during the experiment.
Measurements of IFN-γ, and IL-8
Ninety animals were divided into normal (n=30) and experimental groups (2 groups, n=60). T.
gondii was seeded in a 12 well plate (1 × 10 7 /well), which was incubated with 500 μg/ml of GE/F1 for 24 h. T. gondii treated with 500 μg/ml of GE/F1 was harvested before the injection in the abdominal cavity of mouse, and it was washed with 1X PBS three times. The pellets were also 
Statistical analysis
All results were expressed as mean ± S.E.M. Statistical analysis of the data was performed using Student's t-test and One-way analysis of variance (ANOVA software version 14). The significance level was 2α=0.05.
RESULTS
Effect of GE and GE/F1 on the proliferation of T. gondii-infected C6 cells and T. gondii
T. gondii has various micro-organelles such as mitochondria and ER network. MTT is an established assay performed in many laboratories. We evaluated the effects of ginger, G. glabra and G. biloba extracts on cell proliferation and cell viability of T. gondii using MTT assay. After T.
gondii-infected C6 cells were incubated with various concentrations (30-240 μg/ml) of the extracts for 24 h, their viability was decreased in a dose-and time-dependent manner (Fig. 1) . In particular, GE strongly inhibited the proliferation and viability of T. gondii-infected C6 cells compared with other extracts. T. gondii-infected C6 cells treated with 240 μg/ml of GE/F1 for 24 h exhibited antiproliferation including T. gondii fragmentation and a significant decrease in T. gondii, as well as the morphological changes including cell shrinkage, membrane blebs, and cell fragmentation compared with T. gondii-infected C6 cells (Fig. 2) . As shown in Figs 1-3, GE/F1 effectively inhibited the viability of T. gondii-infected C6 cells and T. gondii compared with SF, which induced the T. gondii-selective growth inhibitory effect against T. gondii, and then PR was measured less than 45 % at concentrations of 240 μg/ml (Fig. 3) . The 50 % inhibitory concentration (IC 50 ) values of GE, GE/F1, and SF against T. gondii were measured as 220.83, 205.56, and 276.81 μg/ml, respectively. These results indicate that GE/F1 effectively caused antiproliferation of T.
gondii-infected C6 cells through the direct inhibition of T. gondii. On the other hand, GE/F1 showed no obvious cytotoxicity against DI TNC1 cells (Fig. 4) . 
Inhibitory effect of GE/F1 on PVM formed by T. gondii proliferation in host cells
Modulation of GE/F1 on apoptotic proteins in T. gondii-infected C6 Cells
The caspase-3, bax, p53 and p21 proteins play crucial roles in the regulation of cell cycle progression during cell division (Morgan 1995) . In this study, we evaluated the inhibitory effects of GE/F1 on the apoptotic signaling proteins which cause cell cycle arrest and apoptosis during the proliferation stage of T. gondii in T. gondii-infected C6 cells. The p53 is a tumor-suppressor protein of the cell death pathway, and the p21 functions as a regulator of cell cycle progression at G 1 /S or G 2 /M transition in response to a variety of stress stimulation. The caspase-3 and bax are indicator proteins of the mitochondria pathway of the cell death mechanism. The expression of p53, p21, caspase-3 and bax activated by intracellular proliferation of T. gondii was markedly decreased in T.
gondii-infected C6 cells treated with GE/F1 compared with both T. gondii-infected C6 cells treated
with SF and T. gondii-infected C6 cells (T. gondii infection positive group) (Fig. 6) . These results 13 suggest that GE/F1 effectively blocked apoptosis of C6 cells induced by T. gondii invasion through the direct inhibition of T. gondii. /F1 on the viability and proliferation of T. gondii in T. gondii-infected mice T. gondii is a parasite which induces serious infectious diseases such as a brain injury and immune deficiency in human and animals. For this reason, we evaluated the antiproliferative effect of GE/F1 against the proliferation and growth of T. gondii in T. gondii-infected mice. The mice were observed during the period of the experiment after the injection of T. gondii treated with 250 and 500 μg/ml of GE/F1 for 24 h. As mentioned above, T. gondii-infected mice treated with 500 μg/ml of GE/F1 showed higher viability compared with T. gondii-infected mice and T. gondii-infected mice treated with 250 μg/ml of GE/F1, and the mice maintained the activity and dynamics like normal group. In addition, there was a significant difference of the survival rate between T. gondii-infected mice and T. gondii-infected mice treated with GE/F1 (Fig. 7) . These results demonstrate that GE/F1 has anti-T.
Effects of GE
gondii effects and unique properties which inhibit the proliferation and growth of T. gondii.
Changes of cytokines in T. gondii-infected mice
Cytokines play in endocrine via specific cell surface receptors on their target cells as key players in the regulation of the immune response. They exert their actions during tissue damage leading to inflammation and infections such as parasites, bacteria, virus, and endocrinological autoimmune diseases. Particularly, the release of cytokines such as IFNs (INF-α, β, γ) , and IL-8 which are produced by infections and inflammation is important components of immune response to secrete cytokines that help to activate endocrine system. As shown in Fig. 8 , although secretions of INF-γ, and IL-8 were slightly increased on first day after the injection of T. gondii treated with 500 μg/ml 14 of GE/F1, their levels were not increased during infection periods. On other hands, the concentrations of cytokines in serum of T. gondii-infected mice were rapidly increased compared with normal group. These results demonstrate that GE/F1 effectively inhibited the secretions of INF-γ and IL-8 which are rapidly activated by infections, inflammation, and tissue damage in endocrine system of mice.
DISCUSSION
T. gondii causes serious complication in AIDS/HIV patients, as well as parasite symptoms into brain through extrinsic infection. T. gondii causes spontaneous abortion in pregnant women and the fetal infection through the placenta during pregnancy, which is also one of the important parasites which induce zoonosis. When host cells are infected by a parasite, the host cells activate protective systems including the immune-response and defensive mechanism against mechanism of parasitic invasion and stimulation of secretion released from the parasite. Particularly, IFN-γ produced by helper T-cells accelerates the differentiation of T lymphocytes through the signaling transport of the STAT1 and T-bet, and then they activate anti-protozoa system which causes the resistance against T. gondii invasion in vivo. However, T. gondii inhibits the production of IL-4, the activity of caspase-3 and the release of cytochrome-c from mitochondria after invasion in host cells. T. gondii suppresses apoptotic signals of host cells to induce anti-apoptosis during its proliferation stage in host cells (Laliberte and Carruthers 2008) . In this study, we evaluated the effect of GE/F1 which inhibits the proliferation of T. gondii and the changes of cytokines induced by T. gondii infection through animal testing, and signaling pathways of apoptotic proteins in host cells after T. gondii infection.
In general, apoptotic signaling pathways induce apoptosis through the G 1 /S or G 2 /M transition of the cell cycle by regulating the expression of genes. Among apoptotic proteins, bax and 15 caspase-3 are important indicators related to the mitochondrial signaling pathways that regulate the activation of apoptotic cascade mechanism, and their activity results in the subsequent apoptotic progression (such as caspase-9, -7, -6, Cyto-c, and CAD). The overexpression of p53 induces an increase of bax and p21 expression, and a suppression of bcl-2 expression (Agarwal et al. 1998 ).
Furthermore, p21 is a CKI that inhibits activity of Cyclin-Cdk complex at the G1 or G2 checkpoints of cell cycle, and the expression of p21 is controlled by tumor suppressor p53 at G 1 phase (El-Deiry et al. 1993 , Harper et al. 1993 , Gartel and Radhakrishnan 2005 , Choi et al. 2011 ). These apoptotic Furthermore, activation of the PI3K (phosphoinositol 3 kinase) in infected cells leads to inactivation of Bad and the inhibition of the forkhead transcription factor (FKHR1) in the host cells (Gubbels et al. 2008 ). In the present study, the proliferation of T. gondii and PVM were remarkably inhibited in T. gondii-infected C6 cells treated with GE/F1 compared with T. gondii-infected C6 cells (Fig. 5) .
Although the expression of bax, caspase-3, p53 and p21 was increased in C6 cells after T. gondii infection, their expression was decreased in a concentration-dependent manner in infected cells after treatment with GE/F1 (Fig. 6 ). On the other hand, both p53 and p21 were significantly increased in T. gondii-infected C6 cells and T. gondii-infected C6 cells treated with SF compared 16 with uninfected C6 cells. slightly increased on first day after the injection, the increase of cytokines may be a low response of immune network induced because immune cells recognize the presence of them as foreign substances. In addition, T. gondii-infected mice treated with GE/F1 (500 μg/ml) showed the viability like normal group during the experiment. Taken together, these results indicate that T. gondii-infected host cells induce the activation of cell cycle initiator (p21) and apoptotic mediator (p53, caspase-3 and bax) which cause host cell apoptosis during the proliferative phase (the stage before the release of T. gondii) of T. gondii. The results provide that T. gondii increases inflammatory cytokine secretion in vivo after its infection.
In summary, the results of this study demonstrate that GE/F1 not only has anti-T. gondii effects causing the direct inhibition of T. gondii but also inhibits the activation of apoptotic proteins (p53, p21, caspase-3, and bax) induced by T. gondii proliferation in infected host cells. The results also indicate that GE/F1 has antiparasitic properties which are able to maintain the survival of T.
gondii-infected mice. Therefore, our research findings provide substantial evidence that GE/F1 can 17 be used as a new candidate substance for anti-T. gondii drug development through the blocking of apoptotic proteins in vitro and inflammatory cytokine inhibition in vivo. These results suggest that effective extract and substance derived from medicinal plants may be used as useful medicinal resources for antiparasitic drug. 
Figure legends
